|Bid||28.75 x 800|
|Ask||29.40 x 900|
|Day's range||27.67 - 30.10|
|52-week range||21.20 - 42.89|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||20.66|
|Earnings date||19 Jan 2021 - 25 Jan 2021|
|Forward dividend & yield||1.12 (3.65%)|
|Ex-dividend date||30 Jul 2020|
|1y target est||32.50|
Welcome to the PetMed Express Incorporated, doing business as 1-800-PetMeds, Conference Call to Review the Financial Results for the Second Fiscal Quarter for the quarter ended on September 30, 2020. The increases in sales were due to increases in reorder sales for the quarter, and increases for both new order and reorder sales for the six months.
The pet pharmacy delivered solid revenue and earnings growth. But its bottom-line improvement wasn't quite good enough to impress analysts.
Welcome to the PetMed Express Incorporated, doing business as 1-800-PetMeds, Conference Call to review the financial results for the First Fiscal Quarter ended on June 30, 2020. At the request of the Company, this conference is being recorded. At this time, I would like to turn the call over to the Company's Chief Financial Officer, Mr. Bruce Rosenbloom.